Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1999 3
2001 1
2003 1
2004 1
2005 1
2006 1
2008 1
2010 4
2018 1
2019 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
[Post-intubation tracheal stenosis].
Brichet A, Verkindre C, Ramon P, Marquette CH. Brichet A, et al. Among authors: verkindre c. Rev Mal Respir. 1999 Nov;16(4 Pt 2):685-92. Rev Mal Respir. 1999. PMID: 10897832 Review. French.
[Asthma in the elderly].
Radenne F, Verkindre C, Tonnel AB. Radenne F, et al. Among authors: verkindre c. Rev Mal Respir. 2003 Feb;20(1 Pt 1):95-103. Rev Mal Respir. 2003. PMID: 12709638 Review. French.
[Asthma in the elderly].
Radenne F, Verkindre C, Tonnel AB. Radenne F, et al. Among authors: verkindre c. Rev Mal Respir. 2004 Nov;21(5 Pt 3):8S117-25. Rev Mal Respir. 2004. PMID: 15803546 Review. French.
Omalizumab-induced decrease of FcξRI expression in patients with severe allergic asthma.
Chanez P, Contin-Bordes C, Garcia G, Verkindre C, Didier A, De Blay F, de Lara MT, Blanco P, Moreau JF, Robinson P, Bourdeix I, Trunet P, Le Gros V, Humbert M, Molimard M. Chanez P, et al. Among authors: verkindre c. Respir Med. 2010 Nov;104(11):1608-17. doi: 10.1016/j.rmed.2010.07.011. Epub 2010 Aug 30. Respir Med. 2010. PMID: 20801010 Free article. Clinical Trial.
Indacaterol once-daily is equally effective dosed in the evening or morning in COPD.
Magnussen H, Verkindre C, Jack D, Jadayel D, Henley M, Woessner R, Higgins M, Kramer B; INPUT study investigators. Magnussen H, et al. Among authors: verkindre c. Respir Med. 2010 Dec;104(12):1869-76. doi: 10.1016/j.rmed.2010.08.010. Epub 2010 Sep 20. Respir Med. 2010. PMID: 20850959 Free article. Clinical Trial.
14 results